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Introduction
Juvenile dermatomyositis (JDM) is a rare condition affect-
ing 3 children/million/year. Muscle and skin involvement
are key features. The muscle symptoms are frequently the
main initial focus: formal measures (CMAS and MMT8)
exist to routinely and accurately assess this component of
the disease. However the involvement of skin, and its
assessment, is also a vital aspect. The abbreviated Cuta-
neous Assessment Tool (CAT) encompassing active skin
disease and skin damage, Disease Activity Score (DAS)
and Myositis Intention to Treat Activity Index (MITAX),
both with skin components, have all been suggested to
measure skin disease in JDM; however the optimal tool is
unknown.
Objectives
To compare three tools for assessment of skin disease in
JDM and correlate them with the physician’s 10cm skin
visual analogue scale (physician’s skin VAS) to define
which tool best assesses skin disease.
Methods
Patients recruited to the UK JDM Cohort & Biomarker
Study who fulfil Bohan-Peter criteria for JDM were
included. Each patient was assessed for skin disease using
the CAT, DAS, MITAX and an overall physician’s skin
VAS. Markers of muscle disease (CMAS, MMT8, CK U/
L), inflammatory markers (CRP mg/L and ESR mm/hr)
and overall physician’s global score were also recorded.
Spearman’s correlations (rs) were used to correlate cate-
gorical and continuous variables and a relationship >0.75
was considered strong. A p-value <0.05 was considered
significant.
Results
Between 2012 and 2014, 67 JDM patients were assessed.
59.7% were female. The mean (±SD) age of the patients
was 9.86 ±3.37 years, with mean age at diagnosis
6.59 ±3.42 years and mean disease duration of 3.26 ±3.08
years. The skin section of the DAS had the strongest cor-
relation with the physician’s skin VAS (Table 1). The skin
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Table 1 Spearman’s correlation between items shown as rs and corresponding p value
Physician’s skin VAS n=67 CMAS n=67 MMT8 n=67 CK n=52 CRP n=55 ESR n=54
DAS skin rs 0.795 p<0.001 rs -0.443 p<0.001 rs -0.424 p<0.001 rs 0.176 p 0.212 rs 0.280 p 0.039 rs 0.311 p 0.022
MITAX skin rs 0.594 p<0.001 rs -0.404 p 0.001 rs -0.453 p<0.001 rs 0.177 p 0.210 rs 0.208 p 0.127 rs 0.281 p 0.040
CAT Activity rs 0.623 p<0.001 rs -0.471 p<0.001 rs -0.428 p<0.001 rs 0.157 p 0.267 rs 0.300 p 0.026 rs 0.164 p 0.235
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section of the MITAX and the CAT activity scores were
significantly correlated with the physician’s skin VAS.
DAS skin, MITAX skin and CAT Activity scores were all
negatively correlated with CMAS and MMT8 scores; no
significant correlations were noted with the CK. DAS skin
scores were significantly correlated with both the CRP and
ESR, while the MITAX skin was significantly correlated
only with the ESR, and CAT Activity only with the CRP.
Conclusion
These data demonstrate the potential application of using
a skin assessment tool to evaluate and monitor skin invol-
vement in JDM patients. It also demonstrates that the
DAS skin section appears to be the best of the tools using
the physician’s skin VAS as the gold standard. The DAS
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